Introduction c-Myc is an oncoprotein known to induce proliferation, transformation, and apoptosis in mammalian cells (Amati and Land, 1994) . During the normal cell cycle, c-Myc is required for the G1 to S phase transition (Biro et al., 1993) . Activation of c-Myc expression is sucient to drive quiescent cells into S phase (Eilers et al., 1991) . Although the true mechanism by which cMyc regulates the cell cycle is unknown, recent evidence suggests that c-Myc mediates the release of cyclinD/Cyclin-Dependent Kinase 2 (CDK2) and cyclinE/CDK2 complexes from kinase inhibitor protein p27 (Berns et al., 1997; Pusch et al., 1997; Muller et al., 1997) . The activated cyclin complexes in turn phosphorylate Rb, which upon hyperphosphorylation releases transcription factors that transcribe genes known to facilitate cell cycle progression (Berjersbergen and Bernards, 1996) .
A more traditional role of c-Myc in cell cycle progression is as a direct transcriptional activator. cMyc is a transcription factor of the helix ± loop ± helix class, which must form a heterodimer with Max in order to activate Myc-responsive genes (Amati and Land, 1994) . Two other transcription factors, Mad and Mxi can inhibit transactivation of Myc-responsive genes by heterodimerizing with Max, binding to the same Myc : Max recognition site and blocking transactivation (Amati and Land, 1994) . Known target genes of c-Myc include: ornithine decarboxylase (BelloFernandez et al., 1993) , eIF-4E, eIF-2a (Rosenwald et al., 1993) , and cdc25A (Galaktionov et al., 1996) , critical factors for cell cycle progression.
Paradoxical to the c-Myc role as a proliferating factor, c-Myc expression can also induce apoptosis (Packham and Cleveland, 1994) . In response to IL-3 withdrawal, myeloid progenitor cells, 32D.3, downregulate c-Myc and undergo G1 arrest, whereas forced expression of c-Myc in these IL-3 deprived cells, induces rapid cell death (Askew et al., 1991) . Regulated expression of c-Myc also induces apoptosis in serum deprived Rat1 ®broblasts and Chinese hamster ovary ®broblasts (Evan et al., 1992; Bissonnette et al., 1992) .
Regulation of c-myc is required for dierentiation of several developing tissues. c-Myc protein levels decrease during TPA-stimulated cellular differentiation of myeloid leukemic cells, whereas, Mad and Mxi protein levels increase (Ayer and Eisenman, 1993) . In the gastrointestinal tract, c-Myc is readily detected in immature proliferating cells at the base of the colonic crypts, whereas Mad is restricted to postmitotic dierentiated cells at the apex of the crypts (Chin et al., 1995) . Likewise in skin, the suprabasal cells show an increasing gradient of Mad consistent with the progression of dierentiation in the epidermis (Chin et al., 1995; Hurlin et al., 1995b) . Upon induction of dierentiation of primary human foreskin keratinocytes, levels of c-Myc decreased, whereas, levels of Mad increased (Hurlin et al., 1995a) . However, while there is an inverse relation between c-Myc levels and epidermal dierentiation, the exact role of c-Myc in dierentiation is not clear.
Deregulation of c-Myc has been observed in several cancer types including breast (Nass and Dickson, 1997) , colon (Kopinin, 1993) , lung (Gazdar, 1994) , and lymphomas (Cotter, 1993) . Experimental animal models have also implicated up-regulation of c-myc in skin carcinogenesis. UV-B induced skin tumors in both mouse and rat models were found to have an upregulation of c-Myc expression (Sato et al., 1997; Jin et al., 1992) . The purpose of the present study is to understand the role of c-Myc in epidermal proliferation and dierentiation using a transgenic mouse model, in which c-Myc is overexpressed in the epidermis. Transgenic mice overexpressing c-Myc in the epidermis exhibit abnormal proliferation and dierentiation, which leads to a thickened skin phenotype. Contrary to previous reports that c-myc promotes apoptosis (Packham and Cleveland, 1994) , the ML.myc2 transgenic model exhibits signi®cantly fewer UV-B induced apoptotic cells.
Results

Construction and detection of ML.myc2 transgene
To avoid potential complications from regulatory elements in the 5' non-coding region of the c-myc gene (Bentley and Groudine, 1988) , we inserted the human c-myc cDNA beginning with the second AUG start site (myc2) into the 6.5 kb loricrin expression Figure 1 Transgene construct and expression. Schematic showing structure of the ML.myc2 transgene (A). Founder lines and subsequent transgenic mice were identi®ed by PCR of tail DNA using a primer to the loricrin vector (P1) and a primer to human cmyc cDNA (P2). An RNase protection assay to detect transgene expression was performed on epidermal RNA isolated from 1-dayold pups from the three founder lines (B). The riboprobe, which detects both endogenous loricrin and the ML.myc2 transgene was generated from a PCR fragment containing 50 bp 3' loricrin and 150 bp of 3' non-coding region. Thus, the endogenous mouse loricrin mRNA yields a 200 bp band, whereas the transgene gives the lower 150 bp band. Western analysis was also performed on the intermediate expressing line D4021 (C). Protein samples were collected from the skin of both transgenic ML.myc2 (myc) and normal (wt) pups. Myc transgenic protein was detected by a monoclonal antibody against human Myc. Myc expression ®rst appears on embryonic day 18 (E18) and steadily increases through postnatal day 4 (PN4). Immuno¯uorescence was performed on whole skin of a 6 day ML.myc2 pup (E) and a littermate control (D) using a monoclonal antibody to human c-Myc (red). The counterstain is K14 (green). Yellow stain indicates co-expression of c-Myc and K14. Bar, 100 mm vector, ML.myc2 ( Figure 1A ). Three founder lines D4019, D4020 and D4021 were identi®ed by PCR analysis from tail DNA and subsequently con®rmed as transgene expressors by RNase protection analysis ( Figure 1B ). The riboprobe chosen in this analysis recognizes both the endogenous loricrin transcript (200 bp) and the ML.myc2 transgene transcript (150 bp). Expression levels of the ML.myc2 transgene in each of the three founder lines correlates to the severity of the phenotype. Variation in transgene expression level in the three lines is most likely due to site of integration. Western analysis of epidermis from embryonic day 17 to postnatal day 4 reveals cMyc protein is ®rst detected on embryonic day 18 and increases up to day 4 ( Figure 1C) . Expression of c-Myc throughout the epidermis in ML.myc2 transgenic mice was con®rmed by immunostaining with mAb against human c-Myc ( Figure 1D ).
Hyperplastic/hyperkeratotic skin phenotype in ML.myc2 transgenic mice ML.myc2 pups exhibit a severe hyperkeratotic phenotype, which develops on day 4. The phenotype persists for several more days and then the pups begin to normalize. The three founder lines exhibited a similar phenotype with the severity of the phenotype for each founder line correlating to the RNA expression levels shown by RPA. The hyperkeratotic phenotype consisted of thick, wrinkly skin that appears very¯aky.
Histological analysis of the ML.myc2 epidermis revealed severe hyperplasia and hyperkeratosis, de®ned as increased thickening of the stratum corneum ( Figure 2 ). Hyperplasia was evident by histology on days 1 ± 3 ML.myc2 transgenic pups before a gross phenotype developed on day 4. The ML.myc2 epidermis consisted of a ®vefold increase in the number of layers in the epidermis as compared to a normal littermate. The histology of ML.myc2 transgenic mice epidermis also revealed the appearance of nucleated cells in the stratum corneum.
Increased proliferative index in ML.myc2 transgenic mice
The presence of hyperplasia in ML.myc2 transgenic mice suggested that the transgenic epidermis possess a greater proliferative index. BrdU analysis was employed to compare proliferative rates between the epidermis of ML.myc2 transgenic mice and normal littermates. Pups were injected with BrdU and sacri®ced after 1 h. Skin samples were collected, processed for histology, and stained with FITCconjugated antibodies against BrdU. Increased proliferation is evident in ML.myc2 transgenic pup epidermis as early as postnatal day 1, which increases through day 6 ( Figure 3A ). The epidermis of 6-day old ML.myc2 transgenic pups have a threefold increase in the number of BrdU positive cells in their epidermis ( Figure 3A ) as compared to normal ( Figure 3B ). BrdU positive cells are also detected in the suprabasal layers in the epidermis of ML.myc2 transgenic mice, whereas, BrdU positive cells are only detected in the basal layer of normal mice.
Aberrant expression of dierentiation markers in ML.myc2 transgenic mice
To further investigate whether c-Myc overexpression delays keratinocyte dierentiation, the expression patterns of epidermal dierentiation markers: keratin 1 (K1), keratin 6 (K6), loricrin and ®laggrin were analysed. Each marker was analysed using double Figure 2 H&E histology of the epidermis of ML.myc2 transgenic pups reveals hyperplasia and hyperkeratosis. The ML.myc2 pup (B) displays obvious epidermal hyperplasia (increased thickness of the epidermis), hyperkeratosis (increased thickness in the stratum corneum) and delayed dierentiation (appearance of cells still possessing nuclei above the granular layer) as compared to a normal littermate (A). Bar, 50 mm immuno¯uorescence with keratin 14 (K14) as the counterstain. K14, which is expressed throughout the epidermis and in the outer root sheath of the hair follicles (Kopan and Fuchs, 1989) , was expressed normally in the ML.myc2 transgenic epidermis. In control littermates ( Figure 4A ), K1 displayed a normal diuse expression pattern, staining post mitotic basal cells and all suprabasal cells . However, in the epidermis of ML.myc2 transgenic pups K1 expression was patchy in the suprabasal layers ( Figure 4B ). K6 expression was restricted to the companion layer of the hair follicles in control littermates ( Figure 4C ) . In ML.myc2 transgenic pups, K6 was aberrantly expressed in the epidermis ( Figure 4D ), which is consistent with previously characterized transgenes in the epidermis known to induce hyperplasia (Greenhalgh et al., 1993) . The expression of late stage dierentiation markers, loricrin (Mehrel et al., 1990) and ®laggrin (Rothnagel et al., 1987) , were both expressed throughout the granular layer and the stratum corneum in littermate controls ( Figure 4E ,G). However, both loricrin and ®laggrin staining was reduced in these layers of ML.myc2 transgenic pups ( Figure 4F,H) .
c-Myc overexpression decreases sensitivity to UV-B induced apoptosis in vivo
Pups 424 h old were exposed to 36 kJ/m 2 of UV-B irradiation and sacri®ced 20 h post exposure for collection of skin biopsies. TUNEL analysis was performed on formalin ®xed sections of both control and ML.myc2 transgenic epidermis. The epidermis of Figure 3 ML.myc2 transgenic pups have an increased proliferation rate as compared to a littermate control. Pups ranging from day 1 to day 6 were injected with BrdU and sacri®ced after 1 h. BrdU incorporation was visualized using BrdU antibodies linked to a¯uorescein tag (green). (A) Graph of per cent greater BrdU positive cells in ML.myc2 transgenic pups as compared to littermate controls. Age-matched non-transgenic are 100%. Day 6, ML.myc2 transgenic pups exhibit threefold increase in BrdU labeled cells as compared to the epidermis of a normal littermate. The epidermis of ML.myc2 (C) display suprabasal proliferative cells, whereas proliferation is con®ned to the basal layer in littermate controls (B). The counterstain is K14 (red). Yellow stain indicates the presence of both BrdU and K14. Bar, 100 mm littermate control pups displayed 11.57+1.08 (s.e.m.) of TUNEL positive cells, whereas, the epidermis of the ML.myc2 pups exhibited signi®cantly fewer apoptotic cells, 4.57+0.66 ( Figure 5C ).
Decreased sensitivity to UV-B induced apoptosis is growth factor dependent, in vitro One potential explanation for the reduced sensitivity of ML.myc2 transgenic mice to UV-B irradiation could be the increased thickness of the epidermis. To exclude this possibility, we isolated primary keratinocytes from both ML.myc2 and control mice and exposed these cultures to UV-B irradiation. Consistent with our in vivo results, cultured ML.myc2 keratinocytes were also *threefold less sensitive to UV-B in the presence of growth factor rich ®broblast conditioned media ( Figure  6 ). When growth factors were withheld after UV-B exposure ML.myc2 keratinocytes were just as likely to undergo apoptosis as normal keratinocytes.
Discussion
The skin is a highly regulated organ maintaining tight control of proliferation, dierentiation, and programmed cell death. Alterations in these processes could disrupt the morphology and functions of the epidermis and ultimately lead to carcinogenesis. In the present study, we provide in vivo evidence that overexpression of c-Myc in the epidermis of transgenic mice alters epidermal homeostasis, resulting in epidermal hyperproliferation, delayed terminal differentiation and altered programmed cell death.
Previous transgenic models targeting overexpression of myc to the mammary gland and to kidney glomerular and tubular epithelium exhibit hyperplasia (Schoenerberger et al., 1988; Trudal et al., 1998) . However, the role of myc in epidermal proliferation in vivo has not been documented. In vitro studies on keratinocytes have implicated c-Myc to play a proliferative role. For example, application of TPA to primary keratinocytes, which stimulates proliferation, increases c-Myc protein levels (Rodriguez-Puebla et al., 1998). Conversely, down regulation of c-myc has been shown to be necessary for transforming growth factor-b (TGF-b) to inhibit keratinocyte proliferation (Pietenpol et al., 1990 ). In our current study, we have successfully targeted expression of cmyc to the epidermis of transgenic mice. Profound epidermal hyperplasia coupled with an increase in DNA synthesis in the ML.myc2 epidermis con®rms a potent growth stimulatory role for c-myc in the epidermis. Figure 4 Aberrant expression of epidermal dierentiation in ML.myc2 mice, day 6. Skin samples were cryosectioned and immuno¯uorescence was performed using antibodies against Keratin 1 (green). In normal pups (A) K1 is expressed throughout the suprabasal layers. In the epidermis of ML.myc2 transgenic pups (B), there is a delay in the onset of K1 expression. The counterstain for all sections is K14 (red). Yellow stain indicates co-expression of the dierentiation marker and K14. Keratin 6 (green), which is normally only expressed in the hair follicle (C), is expressed in the interfollicular epidermis of ML.myc2 transgenics (D). ML.myc2 transgenic mouse epidermis (F) has reduced loricrin (green) staining as compared to a normal littermate control (E). ML.myc2 transgenic mouse epidermis (H) has reduced staining of ®laggrin (green) as compared to a littermate control (G). Expanded loricrin and ®laggrin expression is due to the expansion of the granular layer. Bar, 100 mm In contrast to the role of myc in stimulating keratinocyte proliferation, Gandarillas and Watt (1997) have recently reported that c-myc promotes terminal dierentiation of human epidermal stem cells, in vitro. The contrasting eects of myc on keratinocytes observed in vivo vs the previous in vitro study may simply re¯ect a dierential response to myc which is dependent on the presence of appropriate growth and/ or survival factors, as observed in the induction of apoptosis (see below).
Our in vivo results are also consistent with the normal gradient of myc in the epidermis. In normal epidermis c-myc expression is con®ned to the proliferative basal cell layer, whereas the suprabasal (terminally dierentiated) layers of the epidermis exhibit decreased c-myc expression levels and increased expression levels of c-myc inhibitors Mad1, Mad3 and Mad4 (Chin et al., 1995; Hurlin et al., 1995a,b) . It appears that the switch from Myc-Max to Mad-Max heterodimers is necessary for mediating dierentiation in several cell types (Hurlin et al., 1994) . For example, overexpression of myc inhibits dierentiation of hemopoietic cells including both erythroid (Coppola and Cole, 1986 ) and myeloid cells (Larsson et al., 1988) . Upon induction of differentiation of myeloid cells to the monocyte/macrophage lineage, Myc levels decline and Mad-Max heterodimers are predominant (Ayer and Eisenman, 1993) . Consistent with these previous observations, Mad1 null mice exhibit an inhibition in granulocyte dierentiation (Foley et al., 1998) . Taken together these data suggest that the relative levels of Myc and Mad determine the ®ne balance between proliferation and dierentiation.
In addition to the role of myc in both proliferation and dierentiation, c-myc has been shown to induce apoptosis (Packham and Cleveland, 1994) . For example, targeted expression of c-myc in the mammary gland of transgenic mice revealed a signi®cant increase in the number of apoptotic cells (Jager et al., 1997) . To determine whether c-myc overexpression induces apoptosis in the epidermis, we examined the sensitivity of ML.myc2 keratinocytes to UV-B induced apoptosis. Surprisingly, ML.myc2 epidermal keratinocytes exhibited a decreased sensitivity to UV-B induced apoptosis. Although this is a nontraditional role for cmyc in apoptosis, it is not the ®rst account. Exogenous Figure 5 The epidermis of ML.myc2 transgenic pups exhibit a reduced sensitivity to UV-B induced apoptosis. ML.myc2 pups and control littermate pups were exposed to UV-B light. Twenty hours post-irradiation skin sections were collected, ®xed and TUNEL analysis was performed. A typical ®eld of the littermate control epidermis displays three TUNEL positive cells (FITC) in the epidermis (A). The ML.myc2 epidermis displays one TUNEL positive cell in the epidermis (B). Overall the control epidermis has approximately a threefold greater number of apoptotic cells as compared to the epidermis of ML.myc2 transgenic mice (C), Bar, 50 mm overexpression of c-myc in WEHI 231 murine B-cells inhibits apoptosis induced by antibodies to surface immunoglobulins (Wu et al., 1996) . In some leukemic and lymphoid cell lines c-myc levels must decline for glucocorticoid, dexamethasone induced apoptosis (Thompson, 1998) .
Our current in vitro data indicates resistance to UV-B induced apoptosis by Myc requires a growth factor rich environment. Since the ML.myc2 transgenic epidermis possesses a greater number of proliferative cells, these proliferative cells may secrete sucient growth factors for cells to escape from apoptosis. In agreement with our current observation, levels of c-myc mRNA are decreased in cultured normal human keratinocytes in response to UV-B irradiation (Garmyn et al., 1991; Ariizumi et al., 1996) . This down-regulation of c-myc may be a necessary step for the cell to undergo apoptosis. The forced expression of c-Myc in the ML.myc2 primary keratinocytes would thus render the cell resistant to apoptosis in response to UV-B irradiation. Consistent with this theory, c-myc has been shown to be up-regulated in UV-B induced skin tumors in both mouse and rat models, in which tumor cells escaped from apoptosis and underwent clonal expansion (Sato et al., 1997; Jin et al., 1992) .
Similar to previous observations in epidermal transgenic models (Greenhalgh et al., 1995) , normalization of the phenotype in ML.myc2 transgenic mice begins to occur after day 8. Since expression of the transgene is still detectable in adult epidermis (data not shown), the mechanism responsible for normalizing the eect of the ML.myc2 transgene is most likely the same mechanism that is responsible for the transition of highly proliferative neonatal skin to adult skin (Bertsch and Marks, 1982) . This also re¯ects the homeostatic mechanisms that compensate for the imbalance in proliferation induced by oncogenes. However, this homeostasis may only be maintained if the epidermis remains unchallenged. This is evident in previous epidermal transgenic mouse models expressing either ras or transforming growth factor-a (TGF-a), since wounding or TPA stimulation results in rapid papilloma formation (Greenhalgh et al., 1993; Wang et al., 1994) . Preliminary studies suggest that ML.myc2 transgenic mice will respond similarly. Since proliferation was also detected in suprabasal cells in the ML.myc2 epidermis, this suggests deregulation of myc expression prevents these cells from withdrawing from the cell cycle. Thus, if myc also inhibits apoptosis, this would create an environment, which would potentially allow clonal expansion of genetically altered cells, leading to carcinogenesis. Ongoing studies using the ML.myc2 mice will determine the role of myc overexpression in skin carcinogenesis.
Materials and methods
Generation of ML.myc2 transgenic mice
The ML.myc2 construct was generated by subcloning the cDNA of human c-myc with a 5' NotI restriction site and a 3' ClaI restriction site into the 6.5 kb loricrin vector that has undergone site directed mutagenesis to add a multiple cloning site containing NotI and SmaI restriction sites. This 6.5 kb loricrin promoter represents a fragment of the endogenous loricrin which facilitates expression throughout the epidermis. The c-myc cDNA used will generate only the full length mRNA of c-myc2. The ML.myc2 construct was sequenced to con®rm wildtype sequence. The ML.myc2 construct was released from the pGem 7Z-pSL1180-fusion plasmid by BamHI digestion. The puri®ed construct was microinjected into mouse embryos obtained from matings of ICR females with FVB males. Embryos were then placed into the oviduct of pseudopregnant females (Hogan et al., 1986) . ML.myc2 transgenic pups were identi®ed by PCR analysis of isolated tail DNA using speci®c oligonucleotides to the ML.myc2 construct. The ML.myc2 construct is shown in Figure 1a .
RNase protection assay
Skins from both day 1 and day 4 pups were removed and oated on trypsin with EDTA for 518 h to separate the epidermis from the dermis. Total RNA was isolated from the epidermis using RNAzol B (Tel-Test, Friendswood, TX, USA). RNase protection assays using RPA II kit (Ambion, Austin, TX, USA) were performed on ML.myc2 transgenic mice to determine expression levels. A 32 P-labeled riboprobe was generated corresponding to 200 bp spanning both 3' coding and noncoding regions of the endogenous loricrin mRNA to endogenous levels with transgene levels (Wang et al., 1997) . The endogenous loricrin mRNA protects the full 200 bp of the riboprobe, whereas, the transgene protects only 150 bp of the riboprobe.
Western blot analysis
Skin samples were collected from pups ranging in age from embryonic day 17 to postnatal day 4. Protein was extracted from skin samples as previously described (Yuspa et al., 1989) . Equal amounts of protein, as determined by Coomasie staining, were loaded onto a 10% SDS ± PAGE gel and transferred to nitrocellulose membrane. Western blot analysis was performed as previously described (Greenhalgh et al., 1993) and the trasngenic human c-Myc protein was detected using mouse monoclonal antibody against the human c-Myc epitope (Oncogene Science) and the ECL Western Blotting Detection System protocol (Amersham). Figure 6 Decreased sensitivity of ML.myc2 keratinocytes is growth factor dependent. Following UV-B exposure, primary cultures were fed media with or without the growth factor rich ®broblast conditioned media. TUNEL analysis reveals that in the presence of growth factors ML.myc2 keratinocytes are *threefold less likely to undergo apoptosis. If growth factors are withheld, ML.myc2 keratinocytes are no longer protected from UV-B induced apoptosis BrdU labeling analysis ML.myc2 transgenic pups and control littermates were injected (i.p.) with BrdU (Sigma) at 250 mg/kg in 0.9% NaCl and sacri®ced 1 h later. Skin sections were collected and ®xed as described previously (Wang et al., 1995) . BrdU uptake was detected using¯uorescein isothiocyanate-conjugated mAb to BrdU (Becton Dickenson). Skin sections were also counterstained with guinea-pig antiserum to mouse K14. K14 was visualized with biotinylated anti-guinea-pig IgG (Vector Laboratories) and Streptavidin-Texas Red (GIBCO).
Histological analysis
Skin sections were collected and ®xed in 10% formalinneutral buer. Samples were then embedded in paran, sectioned and stained with hematoxylin and eosin.
Immuno¯uorescence
Skin samples were embedded in OCT (Miles) and stored at 7708C prior to sectioning. Frozen sections were incubated with a guinea-pig antibody against K14 and rabbit antibodies against keratins K1 and K6, loricrin, and ®laggrin. K14 was visualized with biotinylated goat anti-guinea-pig IgG and Streptavidin-Texas Red. The rabbit antibodies were visualized with¯uorescein isothiocyanate-labeled anti-rabbit IgG (Dakopatts). c-Myc expression was visualized using mouse mAb against human c-Myc (Oncogene Science) along with biotinylated goat anti-mouse IgG and Streptavidin-Texas Red. Keratin 14 was visualized in these sections using rabbit antibodies against keratin 14 and a secondary¯uorescein isothiocyanate-labeled anti-rabbit IgG.
TUNEL analysis on whole skin
Pups 524 h old were exposed to 36 kJ/m 2 of UV-B irradiation. Twenty hours after exposure, skin samples were collected and ®xed in 10% formalin neutral buer. Samples were embedded in paran and sectioned. Paran sections were analysed by the Promega Apoptosis Detection System, Fluorescein (Promega). The percentage of TUNEL positive cells was determined by the number of apoptotic cells over the number of cells scored. Experiments were performed in triplicate.
TUNEL analysis on primary cultures
Keratinocytes from control and ML.myc2 pups were isolated and cultured to 80% con¯uence as previously described (Yuspa et al., 1989) . Cultures were maintained in nondierentiating conditions. Cultured keratinocytes were irradiated with 4 kJ/m 2 UV-B. After irradiation, media with or without growth factors from ®broblast conditioned media was added back to primary cultures. Six hours post-exposure, cells were ®xed in 10% formalin and TUNEL analysis was performed. Experiments were performed under culture conditions that maintain keratinocytes in a proliferative, non-dierentiated state. Experiments were performed in triplicate.
Abbreviations ML.myc2, human myc2 expressed from a mouse 6.5 kb loricrin promoter; TPA, 12-O-tetradecanoylphorbol-13-acetate; BrdU, bromodeoxyuridine.
